De Novo device
Rho
16 Bit, Inc. · Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density (SAO, Class II) · First FDA decision Apr 9, 2024, newest Apr 9, 2024Osteoporosis and fragility fractures
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
5
Naming "Rho"
MAUDE reports
20
Brand "Rho", since 2015
PubMed studies
76,342
Mentioning "Rho"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Rho
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- RhoNew device typeBreakthroughDe Novo
DEN230023 · Decided Apr 9, 2024 · 372 days after receipt
Device type: Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density (SAO) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Bone (Mineral) Density StudiesNational determinationOn the books150.3Updated Nov 4, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Rho", any status and sponsor, newest update first.
Tan Tock Seng HospitalAcademic, hospital or other
NCT06412237 · 8 participants · Start Jun 1, 2024 · Primary completion Jan 27, 2026
Device: RELab tenoexo · For: Stroke
Sites: Singapore, Singapore
Hospices Civils de LyonAcademic, hospital or other
NCT02792010 · 31 participants · Start May 2015 · Primary completion Jan 2016
Device: Hip cartilage MRI · For: Healthy Volunteers
Sites: Lyon, France
University of Wisconsin, MadisonAcademic, hospital or other
NCT06830005 · 800 participants · Start Jun 1, 2025 · Primary completion Dec 1, 2025
Device: Rho AI software · For: Osteopenia or Osteoporosis
Sites: Madison, Wisconsin
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Rho", and for the whole product code for context.
This brand
20 reports: 19 malfunction, 0 injury, 0 death
Whole product code SAO
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
2250051-2022-00016 · Received Mar 3, 2022 · Event dated Feb 8, 2022
Device type: Blood Grouping Reagent (QHR)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2250051-2020-00050 · Received Sep 29, 2020 · Event dated Aug 12, 2020
Device type: Blood Grouping Reagent (QHR)
Device problem as coded: False Positive Result
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2250051-2020-00049 · Received Sep 29, 2020 · Event dated Aug 12, 2020
Device type: Blood Grouping Reagent (QHR)
Device problem as coded: False Positive Result
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Rho"[tiab]. The summary above synthesizes these.
- Fast-cycling Rho GTPases.
Aspenström P · Small GTPases · 2020Research Support, Non-U.S. Gov't, Review
- Structural Dynamics of Rho GTPases.
Lin Y, Zheng Y · J Mol Biol · 2025Review, Research Support, N.I.H., Extramural
- Rho GTPases and spermatogenesis.
Lui WY, Lee WM, Cheng CY · Biochim Biophys Acta · 2003Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Structural basis of Rho-dependent transcription termination.
Molodtsov V, Wang C, Firlar E, et al. · Nature · 2023Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Rho GTPases in neurodegeneration diseases.
DeGeer J, Lamarche-Vane N · Exp Cell Res · 2013Research Support, Non-U.S. Gov't, Review
- Rho GTPase regulatory proteins in podocytes.
Matsuda J, Asano-Matsuda K, Kitzler TM, et al. · Kidney Int · 2021Research Support, Non-U.S. Gov't, Review
- Rho GTPase signaling in rheumatic diseases.
Zeng R, Zhuo Z, Luo Y, et al. · iScience · 2022Review
- Rho-dependent termination enables cellular pH homeostasis.
Bhardwaj K, Kalita A, Verma N, et al. · J Bacteriol · 2024Research Support, Non-U.S. Gov't
- Rho-dependent transcription termination is the dominant mechanism in Mycobacterium tuberculosis.
Ahmad E, Mitra A, Ahmed W, et al. · Biochim Biophys Acta Gene Regul Mech · 2023Research Support, Non-U.S. Gov't
- RHO GTPases in cancer: known facts, open questions, and therapeutic challenges.
Bustelo XR · Biochem Soc Trans · 2018Research Support, Non-U.S. Gov't, Review
- Deregulation of Rho GTPases in cancer.
Porter AP, Papaioannou A, Malliri A · Small GTPases · 2016Review
- Rho GTPases in platelet function.
Aslan JE, McCarty OJ · J Thromb Haemost · 2013Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code SAO.
- OsteoSight Spine (v1)Naitive Technologies, Ltd. · 510(k) 2026
- DeepXray SpinaAlpha Intelligence Manifolds, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.